BD (NYSE:BDX) announced today that it completed its previously announced acquisition of pharmacy automation company Parata Systems. Franklin Lakes, New Jersey-based BD announced last month that it partnered with private equity firm Frazier Healthcare Partners to acquire Parata Systems at a purchase price of $1.525 billion. Parata Systems provides medication adherence packaging technology and perpetual […]
BD
BD launches combination COVID-19, flu, RSV diagnostic test
BD (NYSE:BDX) today announced it has launched a new molecular diagnostic combination test for SARS-CoV-2, influenza A and B and respiratory syncytial virus (RSV) following CE mark approval. The BD Max test uses a single nasal swab or nasopharyngeal swab sample to determine if a patient has COVID-19, the flu or RSV. Franklin Lakes, N.J.-based […]
BD voluntarily recalls intraosseous products
BD (NYSE:BDX) announced that it issued a voluntary recall for select lots of a trio of its intraosseous products. Franklin Lakes, New Jersey-based BD’s recall covers its Intraosseous Needle Set Kits, Intraosseous Manual Driver Kits and Intraosseous Powered Drivers. According to a news release, certain lots within the expiration date of the affected products may […]
BD, Mayo Clinic team up to improve patient care
BD (NYSE:BDX) announced today that it will collaborate with Mayo Clinic Platform to perform detailed post-market surveillance. Franklin Lakes, New Jersey-based BD’s collaboration with Mayo Clinic Platform will access de-identified patient data from the Mayo Clinic Platform_Discover to perform post-market surveillance of the company’s products and fuel innovation, unlocking a faster, more efficient path to […]
BD and CerTest Biotec team up on molecular monkeypox diagnostic test
Becton, Dickinson and Co. and CerTest Biotec announced a partnership to develop a molecular diagnostic test for the monkeypox virus. The CDC is tracking a monkeypox outbreak in the United States and other countries that don’t normally report cases of the infectious virus, which causes a rash and lesions. The virus is mainly shared through […]
BD appoints new president of medical segment
BD (NYSE:BDX) announced today that it appointed Simon Campion as EVP and president of the company’s medical segment. Franklin Lakes, New Jersey-based BD announced in March that Alberto Mas, who held the same roles Campion will assume, intended to retire. Campion’s position will be made effective on July 1, 2022. Mas, 60, informed the company of […]
BD to purchase pharmacy automation firm Parata Systems
BD (Becton, Dickinson and Company) (NYSE:BDX) has partnered with the private equity firm Frazier Healthcare Partners to acquire Parata Systems, a provider of pharmacy automation solutions. The purchase price of the acquisition is $1.525 billion. Founded in 2006, Parata Systems offers a range of products and services, including medication adherence packaging technology and perpetual inventory […]
BD, government warn on cybersecurity issues with BD’s Pyxis, Synapsys systems
The U.S. Cybersecurity & Infrastructure Security Agency (CISA) today released advisories on two products from BD (NYSE:BDX). Vulnerabilities with the BD Pyxis automated medication dispensing system and the BD Synapsys microbiology informatics software were voluntarily reported by Franklin Lakes, New Jersey–based BD through the CISA coordinated vulnerability disclosure program. The BD Pyxis’ vulnerability is labeled […]
BD launches automated infectious disease diagnostic platform in the U.S.
BD (NYSE:BDX) announced today that it began the U.S. launch of its new, fully automated, high-throughput diagnostic platform. Franklin Lakes, New Jersey-based BD designed the BD COR MX instrument option, which now has FDA 510(k) clearance, for molecular diagnostics for infectious disease. According to a news release, the first test available on the instrument option […]
BD ticks up as Q1 earnings beat The Street
BD (NYSE:BDX) shares are on the rise today on first-quarter results that came in well ahead of the consensus forecast. The Franklin Lakes, New Jersey-based company posted profits of $431 million, or $1.50 per share, on sales of just over $5 billion for the three months ended March 31, 2022, for a 55.6% bottom-line gain […]
Medtech CEOs sound off on semiconductor shortage, pushing Biden administration for prioritization
AdvaMed continues to push the Biden administration to prioritize medical device manufacturers for semiconductor supplies. With medtech companies still struggling to source chips amid a global shortage, the industry association held a meeting this week with some of its members and Secretary of Commerce Gina Raimondo to make their case. “Semiconductor chips are crucial to […]